SiriusPoint (SPNT) Competitors $19.80 +0.42 (+2.17%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$19.79 -0.01 (-0.05%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SPNT vs. BNRE, VOYA, JXN, ESNT, ACT, OSCR, BWIN, FG, PLMR, and GSHDShould you be buying SiriusPoint stock or one of its competitors? The main competitors of SiriusPoint include Brookfield Reinsurance (BNRE), Voya Financial (VOYA), Jackson Financial (JXN), Essent Group (ESNT), Enact (ACT), Oscar Health (OSCR), Baldwin Insurance Group (BWIN), F&G Annuities & Life (FG), Palomar (PLMR), and Goosehead Insurance (GSHD). These companies are all part of the "insurance" industry. SiriusPoint vs. Its Competitors Brookfield Reinsurance Voya Financial Jackson Financial Essent Group Enact Oscar Health Baldwin Insurance Group F&G Annuities & Life Palomar Goosehead Insurance SiriusPoint (NYSE:SPNT) and Brookfield Reinsurance (NYSE:BNRE) are both mid-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership. Do analysts prefer SPNT or BNRE? SiriusPoint presently has a consensus price target of $21.00, suggesting a potential upside of 6.06%. Given SiriusPoint's stronger consensus rating and higher possible upside, research analysts plainly believe SiriusPoint is more favorable than Brookfield Reinsurance.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SiriusPoint 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00Brookfield Reinsurance 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, SPNT or BNRE? SiriusPoint has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500. Comparatively, Brookfield Reinsurance has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500. Does the media refer more to SPNT or BNRE? In the previous week, SiriusPoint had 1 more articles in the media than Brookfield Reinsurance. MarketBeat recorded 2 mentions for SiriusPoint and 1 mentions for Brookfield Reinsurance. Brookfield Reinsurance's average media sentiment score of 0.75 beat SiriusPoint's score of 0.63 indicating that Brookfield Reinsurance is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SiriusPoint 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Brookfield Reinsurance 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is SPNT or BNRE more profitable? SiriusPoint has a net margin of 6.30% compared to Brookfield Reinsurance's net margin of 0.10%. SiriusPoint's return on equity of 7.78% beat Brookfield Reinsurance's return on equity.Company Net Margins Return on Equity Return on Assets SiriusPoint6.30% 7.78% 1.33% Brookfield Reinsurance 0.10%0.14%0.01% Do insiders and institutionals hold more shares of SPNT or BNRE? 52.8% of SiriusPoint shares are owned by institutional investors. Comparatively, 7.2% of Brookfield Reinsurance shares are owned by institutional investors. 11.7% of SiriusPoint shares are owned by insiders. Comparatively, 1.0% of Brookfield Reinsurance shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher earnings & valuation, SPNT or BNRE? Brookfield Reinsurance has higher revenue and earnings than SiriusPoint. SiriusPoint is trading at a lower price-to-earnings ratio than Brookfield Reinsurance, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSiriusPoint$2.60B0.89$199.90M$0.9620.63Brookfield Reinsurance$9.35B1.00$796M$0.29221.31 SummarySiriusPoint beats Brookfield Reinsurance on 11 of the 17 factors compared between the two stocks. Get SiriusPoint News Delivered to You Automatically Sign up to receive the latest news and ratings for SPNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SPNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPNT vs. The Competition Export to ExcelMetricSiriusPointINS IndustryFinance SectorNYSE ExchangeMarket Cap$2.31B$20.83B$12.20B$20.68BDividend YieldN/A2.93%5.53%3.71%P/E Ratio20.6313.8120.0528.10Price / Sales0.892.1126.1036.76Price / Cash17.1317.8521.7022.53Price / Book1.334.142.284.58Net Income$199.90M$1.60B$1.00B$985.54M7 Day Performance-3.21%0.09%2.25%2.79%1 Month Performance2.15%4.01%3.69%4.37%1 Year Performance63.77%21.62%541.99%15.08% SiriusPoint Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPNTSiriusPoint1.3278 of 5 stars$19.80+2.2%$21.00+6.1%+63.8%$2.31B$2.60B20.631,072BNREBrookfield ReinsuranceN/A$61.67+1.0%N/A+51.6%$8.97B$9.35B212.6660News CoverageVOYAVoya Financial4.9846 of 5 stars$71.01+0.5%$82.08+15.6%+4.2%$6.80B$8.05B13.4010,000JXNJackson Financial1.683 of 5 stars$88.77-0.8%$94.80+6.8%+20.5%$6.39B$3.27B86.193,970Positive NewsESNTEssent Group4.4683 of 5 stars$60.72+0.1%$63.29+4.2%+11.7%$6.15B$1.24B8.89350News CoveragePositive NewsACTEnactN/A$37.15+1.0%$35.00-5.8%+24.0%$5.52B$1.20B8.37500Trending NewsOSCROscar Health1.463 of 5 stars$21.53+5.5%$16.50-23.4%-1.5%$5.20B$9.18B76.892,400Trending NewsAnalyst ForecastGap UpHigh Trading VolumeBWINBaldwin Insurance Group2.2766 of 5 stars$42.81+0.3%$44.83+4.7%+10.9%$5.06B$1.39B-82.334,116Positive NewsFGF&G Annuities & Life4.1622 of 5 stars$31.94-0.6%$44.33+38.8%-14.2%$4.33B$5.74B8.471,338PLMRPalomar3.7047 of 5 stars$154.25+0.6%$174.17+12.9%+77.1%$4.10B$553.86M30.79150News CoverageAnalyst DowngradeGSHDGoosehead Insurance4.2256 of 5 stars$105.51+3.0%$115.40+9.4%+84.2%$3.84B$314.51M88.661,580 Related Companies and Tools Related Companies Brookfield Reinsurance Competitors Voya Financial Competitors Jackson Financial Competitors Essent Group Competitors Enact Competitors Oscar Health Competitors Baldwin Insurance Group Competitors F&G Annuities & Life Competitors Palomar Competitors Goosehead Insurance Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SPNT) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SiriusPoint Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SiriusPoint With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
